20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-21-NORVITAMIN-D3
Compound with spectra: 1 NMR
![20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-21-NORVITAMIN-D3](/api/compound/3JS8xSmvzVu.png?ph=true&h=300&w=458 "20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-21-NORVITAMIN-D3")
| SpectraBase Compound ID | 3JS8xSmvzVu |
|---|---|
| InChI | InChI=1S/C38H70O3Si2/c1-29-31(27-32(40-42(10,11)35(2,3)4)28-34(29)41-43(12,13)36(5,6)7)22-21-30-19-17-25-38(26-18-20-33(30)38)24-16-14-15-23-37(8,9)39/h21-22,32-34,39H,1,14-20,23-28H2,2-13H3/b30-21+,31-22-/t32-,33+,34+,38-/m1/s1 |
| InChIKey | KPQCHROAERHDLG-OGORPLFKSA-N |
| Mol Weight | 631.1 g/mol |
| Molecular Formula | C38H70O3Si2 |
| Exact Mass | 630.486349 g/mol |
| Enantiomer InChIKey | KPQCHROAERHDLG-XGKPLEBHSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD2Cl2 |
20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-22-HOMO-21-NORVITAMIN-D3
20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-22,23-DIHOMO-21-NORVITAMIN-D3
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aS)-7a-(4-hydroxy-4-methyl-pentyl)-1-isopropenyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
1-.alpha.-Hydroxy-20-oxo-pregnacalciferol
9,10-Secocholesta-5,7,10(19)-triene-3,21,25-triol, (3.beta.,5Z,7E)-
25S,26-Dihydroxy-cholecalciferol
25-HYDROXY-5,6-TRANS-VITAMIN-D3
9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3.beta.,5Z,7E)-
25-HYDROXYVITAMIN-D3
Ergocalciferol II
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of Novel Analogues of 1α,25-Dihydroxyvitamin D3 with Side Chains at C-18 | The Journal of Organic Chemistry | 2004 |